Abstract
Last week, deCODE Genetics released the first-ever breast cancer risk test designed to cover common forms of the disease. Many oncologists and geneticists decried the $1625 test as premature because it includes just seven genetic variants out of the dozens or hundreds driving breast cancer that scientists expect to find soon.

This publication has 0 references indexed in Scilit: